Rawan Latif, PharmD

Senate HELP Committee Hearing Spotlights The 340B Program's Growth And Impact On Patients

ACIP Narrows Vaccine Recommendations For COVID-19 And MMRV, But Preserves Existing Recommendation For Hepatitis B

FDA Narrows COVID-19 Vaccine Approvals And Ends EUAs In Advance Of ACIP Meeting Later This Month

FTC And DOJ Host Final Listening Session On Drug Prices

ACIP Meeting Reflects Shift In Dynamics Around Vaccine Policy